In a significant move, China Investment Corp (CIC), the $1.3 trillion sovereign wealth fund of China, is on the verge of finalizing the sale of approximately $1 billion in stakes across various US private equity funds. According to Bloomberg, Ardian, a leading global private investment house, is among the final bidders for this extensive portfolio, which includes investments in well-known funds managed by Carlyle, Hellman & Friedman, and Welsh Carson Anderson & Stowe.
This transaction is part of CIC's broader strategy to scale back its exposure to US private markets, a trend that has been observed among many global institutional investors this year. The sale could become one of the largest secondary sales in the private equity market, reflecting CIC's intent to generate liquidity by utilizing the secondary market. Earlier this year, Ardian raised a robust $30 billion secondary fund, positioning itself as one of the most active buyers in this space.
CIC's decision to divest follows a previous attempt to sell similar positions in funds managed by Carlyle, KKR, and TPG, which was paused mid-year but has since been revived. As of the end of 2023, alternatives comprised 48% of CIC's total assets, with nearly two-thirds of its global portfolio overseen by external managers.
The strategic rationale behind this sale aligns with a growing trend among institutional investors to reduce illiquid dollar-denominated holdings. Other prominent institutions, including Harvard University and Singapore’s GIC, have also sought to offload large portfolios of private equity stakes this year, underscoring a shift towards increasing liquidity.
The timeline for the deal's closure has not been explicitly detailed, but CIC's ongoing negotiations with Ardian suggest that completion is imminent. Once finalized, this transaction is likely to have significant implications for CIC's asset management strategy and may influence market sentiment regarding private equity investments.
From a regulatory standpoint, while specific antitrust considerations have not been disclosed, large transactions like this typically require scrutiny to ensure compliance with market regulations. As the deal unfolds, stakeholders will be closely watching its impact on CIC's portfolio and the broader private equity landscape.